The Financial Statements for Goodwin, Inc

question 9

Multiple Choice

The financial statements for Goodwin, Inc., and Corr Company for the year ended December 31, 20X1, prior to Goodwin's acquisition business combination transaction regarding Corr, follow (in thousands) :

On December 31, 20X1, Goodwin issued $600 in debt and 30 shares of its $10 par value common stock to the owners of Corr to acquire all of the outstanding shares of that company. Goodwin shares had a fair value of $40 per share.
Goodwin paid $25 to a broker for arranging the transaction. Goodwin paid $35 in stock issuance costs. Corr's equipment was actually worth $1,400 but its buildings were only valued at $560.
Compute the consolidated expenses for 20X1.

• A) $1,980.
• B) $2,005.
• C) $2,040.
• D) $2,380.
• E) $2,405.

---

Definitions:

Sinus Drug

Medication intended to treat sinus conditions, often focusing on reducing inflammation, congestion, or infection within the sinus cavities.

Significance Level

The threshold chosen by the researcher for rejecting the null hypothesis; often denoted by alpha (α) and used in hypothesis testing.

Mousetrap

A device designed to catch or kill mice, typically involving a spring-loaded mechanism.

Alternative Hypothesis

A statement in hypothesis testing that proposes a difference or association, contrasting with the null hypothesis which suggests no effect.